<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03544242</url>
  </required_header>
  <id_info>
    <org_study_id>IRB-160901003</org_study_id>
    <nct_id>NCT03544242</nct_id>
  </id_info>
  <brief_title>Nitrite Infusion in Islet Cell Transplantation</brief_title>
  <official_title>Nitrite Infusion in Islet Cell Transplantation: Test of Clinical Efficacy and Determination of Cytoprotective Mechanisms</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Alabama at Birmingham</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Alabama at Birmingham</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study seeks to investigate the effects of administering nitrite to pancreatic islet
      cells that have been removed from a patient for autotransplantation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients diagnosed with chronic pancreatitis or recurrent acute pancreatitis may acquire
      insulin-dependent diabetes due to islet cell destruction. Therefore, islet cell
      autotransplantation is the optimal therapeutic approach for many of these patients. Islet
      cell autotransplantation is typically done by excision of the pancreas, followed by isolation
      of the islet cells and then infusion of these cells into the sinusoids of the liver.
      Isolation of the islet cells occurs in an ischemic and hypoxic environment, resulting in
      ischemia reperfusion (IR) injury and destruction of islet cells following infusion into the
      sinusoids. Hence, strategies to prevent IR injury and subsequent islet cell destruction, such
      as the administration of inhaled nitric oxide (NO) or sodium nitrite (NaNO2) could enhance
      islet cell survival following reperfusion, also decreasing long-term insulin requirement. The
      purpose of this study is to determine if NO administered by infusion in patients undergoing
      islet cell auto transplantation, will inhibit islet cell destruction, increase diabetes cure
      rate (decrease the amount of and/or the need for long-term insulin requirement), decrease the
      ischemic injury (reduces the injury to the islet cells from a decrease in oxygen levels
      during procurement of the islet cells) during islet cell procurement, and decrease IR injury
      following islet cell infusion. The primary endpoints of the study are exogenous insulin use,
      HgbA1c levels post-operatively, and blood glucose levels.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Lack of eligible subjects, lack of staffing
  </why_stopped>
  <start_date type="Actual">May 7, 2017</start_date>
  <completion_date type="Actual">June 27, 2019</completion_date>
  <primary_completion_date type="Actual">June 27, 2019</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Prior to infusion blood glucose serum levels</measure>
    <time_frame>Between the time of induction and the time immediately prior to infusion of either nitrite or saline</time_frame>
    <description>Blood serum glucose levels will be measured from a blood sample of the amount of 3-5 cc.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pre-islet cell infusion blood serum glucose levels</measure>
    <time_frame>Five minutes prior to the infusion of islet cells</time_frame>
    <description>Blood serum glucose levels will be measured from a blood sample of the amount of 3-5 cc.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>20 minutes after islet cells blood serum glucose levels</measure>
    <time_frame>20 minutes after the infusion of Islet Cells</time_frame>
    <description>Blood serum glucose levels will be measured from a blood sample of the amount of 3-5 cc.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>40 minutes after islet cells blood serum glucose levels</measure>
    <time_frame>40 minutes after the infusion of Islet Cells</time_frame>
    <description>Blood serum glucose levels will be measured from a blood sample of the amount of 3-5 cc.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>24 hours post operative blood samples serum glucose levels</measure>
    <time_frame>24 hours post operatively</time_frame>
    <description>Blood serum glucose levels will be measured from a blood sample of the amount of 3-5 cc.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>48 hours post operative blood samples serum glucose levels</measure>
    <time_frame>48 hours post operatively</time_frame>
    <description>Blood serum glucose levels will be measured from a blood sample of the amount of 3-5 cc.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>72 hours post operative blood samples serum glucose levels</measure>
    <time_frame>72 hours post operatively</time_frame>
    <description>Blood serum glucose levels will be measured from a blood sample of the amount of 3-5 cc.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>96 hours post operative blood samples serum glucose levels</measure>
    <time_frame>96 hours post operatively</time_frame>
    <description>Blood serum glucose levels will be measured from a blood sample of the amount of 3-5 cc.</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">4</enrollment>
  <condition>Diabetes</condition>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Pre-Isolation Infusion</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Post-Isolation Infusion</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Control</intervention_name>
    <description>A saline infusion will be administered during the pre-isolation and post-isolation phases.</description>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Pre-Isolation Infusion</intervention_name>
    <description>A nitrite infusion will be administered during the pre-isolation phase and a saline infusion will be administered during the post-isolation phase.</description>
    <arm_group_label>Pre-Isolation Infusion</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Post-Isolation Infusion</intervention_name>
    <description>A saline infusion will be administered during the pre-isolation phase and a nitrite infusion will be administered during the reperfusion phase.</description>
    <arm_group_label>Post-Isolation Infusion</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients greater than or equal to 18 years of age

          -  Scheduled to undergo Islet Cell auto-transplantation by Dr. Jared White or Dr. Bart
             Rose

          -  Subjects who can provide informed written consent and are willing to do so

        Exclusion Criteria:

        -Any patient with liver disease or unsuitable for surgery (as determined by the surgeon)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Blair Smith, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Alabama at Birmingham</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Alabama at Birmingham</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35294</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>May 21, 2018</study_first_submitted>
  <study_first_submitted_qc>May 21, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 1, 2018</study_first_posted>
  <last_update_submitted>June 27, 2019</last_update_submitted>
  <last_update_submitted_qc>June 27, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 1, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Alabama at Birmingham</investigator_affiliation>
    <investigator_full_name>Blair Smith</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Diabetes</keyword>
  <keyword>Insulin Resistance</keyword>
  <keyword>Nitrite</keyword>
  <keyword>Pancreatic islet cells</keyword>
  <keyword>Autotransplantation</keyword>
  <keyword>Ischemia reperfusion injury</keyword>
  <keyword>Mitigation</keyword>
  <keyword>Cure</keyword>
  <keyword>Nitric oxide</keyword>
  <keyword>Sodium nitrite</keyword>
  <keyword>Islet cell</keyword>
  <keyword>Survival</keyword>
  <keyword>Pancreas</keyword>
  <keyword>Liver</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

